AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LIGHT CHAIN AMYLOIDOSIS: A SINGLE CENTER REPORT
Context: High dose intravenous melphalan followed by Autologous Hematopoietic Stem Cell Transplant (ASCT) has been as essential part of light chain (AL) amyloidosis since 1990s. Patients who achieve complete hematologic response following ASCT have better Overall Survival (OS). However Transplant-Re...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-10-01
|
| Edice: | Hematology, Transfusion and Cell Therapy |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2531137924019916 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
